Notably, Lu et al. reported that shikonin unexpectedly induced PKM2 nuclear translocation and the transcription of BAG3, a gene related to sustained cell survival, suggesting that a combination of a BAG3 inhibitor and shikonin may exhibit better anti-HCC efficacy [85]. This evidence concerns the gene BAG3 and hepatocellular carcinoma.